FR2316943A1 - Pyrrolidones et medicaments qui en contiennent - Google Patents
Pyrrolidones et medicaments qui en contiennentInfo
- Publication number
- FR2316943A1 FR2316943A1 FR7619563A FR7619563A FR2316943A1 FR 2316943 A1 FR2316943 A1 FR 2316943A1 FR 7619563 A FR7619563 A FR 7619563A FR 7619563 A FR7619563 A FR 7619563A FR 2316943 A1 FR2316943 A1 FR 2316943A1
- Authority
- FR
- France
- Prior art keywords
- pyrrolidons
- products containing
- medicinal products
- medicinal
- products
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19752528664 DE2528664A1 (de) | 1975-06-27 | 1975-06-27 | Pyrrolidone und verfahren zu ihrer herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2316943A1 true FR2316943A1 (fr) | 1977-02-04 |
FR2316943B1 FR2316943B1 (fr) | 1978-11-03 |
Family
ID=5950059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7619563A Granted FR2316943A1 (fr) | 1975-06-27 | 1976-06-28 | Pyrrolidones et medicaments qui en contiennent |
Country Status (14)
Country | Link |
---|---|
JP (1) | JPS525764A (fr) |
AT (1) | AT365575B (fr) |
BE (1) | BE843505A (fr) |
CH (1) | CH623809A5 (fr) |
DE (1) | DE2528664A1 (fr) |
DK (1) | DK287476A (fr) |
ES (1) | ES449095A1 (fr) |
FR (1) | FR2316943A1 (fr) |
GB (1) | GB1553595A (fr) |
IL (1) | IL49916A0 (fr) |
LU (1) | LU75235A1 (fr) |
NL (1) | NL7606773A (fr) |
SE (1) | SE7607331L (fr) |
ZA (1) | ZA763802B (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2369260A1 (fr) * | 1976-08-06 | 1978-05-26 | Pfizer | 2-pyrrolidones 1,5-disubstituees et leurs procedes de preparation |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4772601A (en) * | 1988-01-25 | 1988-09-20 | Hoechst-Roussel Pharmaceuticals, Inc. | 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use |
WO2001046140A1 (fr) | 1999-12-22 | 2001-06-28 | Pfizer Products Inc. | Agonistes selectifs au recepteur ep4 dans le traitement de l'osteoporose |
WO2002024647A1 (fr) * | 2000-09-21 | 2002-03-28 | Ono Pharmaceutical Co., Ltd. | Agonistes du recepteur de l'ep4 comprenant comme principe actif des derives de la 8-azaprostaglandine |
SK5562003A3 (en) | 2000-11-27 | 2004-08-03 | Pfizer Prod Inc | EP4 receptor selective agonists in the treatment of osteoporosis |
DK1408961T3 (da) | 2001-07-16 | 2007-11-05 | Hoffmann La Roche | 2 pyrrolidon-derivater som prostanoide agonister |
KR20040015364A (ko) | 2001-07-16 | 2004-02-18 | 에프. 호프만-라 로슈 아게 | Ep4 수용체 작용물질로서의 프로스타글란딘 유사체 |
IL159996A0 (en) | 2001-07-23 | 2004-06-20 | Ono Pharmaceutical Co | Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient |
BR0308738A (fr) * | 2002-03-18 | 2005-01-11 | ||
US6573294B1 (en) * | 2002-05-14 | 2003-06-03 | Allergan, Inc. | 8-azaprostaglandin analogs as agents for lowering intraocular pressure |
CN1735597A (zh) | 2003-01-10 | 2006-02-15 | 霍夫曼-拉罗奇有限公司 | 作为前列腺素激动剂的2-哌啶酮衍生物 |
US7179820B2 (en) | 2003-06-06 | 2007-02-20 | Allergan, Inc. | Piperidinyl prostaglandin E analogs |
WO2014015247A1 (fr) | 2012-07-19 | 2014-01-23 | Cayman Chemical Company, Inc. | Composés de difluorolactame comme agonistes sélectifs du récepteur ep4, destinés à être utilisés dans le traitement de maladies et d'affections médiées par ep4 |
EP3235817B1 (fr) | 2013-03-15 | 2018-12-12 | Cayman Chemical Company, Incorporated | Composés de lactamine en tant qu'agonistes sélectifs du récepteur ep4 destinés à être utilisés dans le traitement des maladies et affections transmises par l'ep4 |
AU2014229065B2 (en) | 2013-03-15 | 2017-03-09 | Cayman Chemical Company, Inc. | Methods of synthesizing a difluorolactam analog |
US9676712B2 (en) | 2013-03-15 | 2017-06-13 | Cayman Chemical Company, Inc. | Lactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions |
AU2014290512A1 (en) | 2013-07-19 | 2015-11-12 | Cayman Chemical Company, Inc. | Methods, systems, and compositions for promoting bone growth |
-
1975
- 1975-06-27 DE DE19752528664 patent/DE2528664A1/de not_active Withdrawn
-
1976
- 1976-06-22 ES ES449095A patent/ES449095A1/es not_active Expired
- 1976-06-22 NL NL7606773A patent/NL7606773A/xx not_active Application Discontinuation
- 1976-06-24 SE SE7607331A patent/SE7607331L/xx unknown
- 1976-06-24 LU LU75235A patent/LU75235A1/xx unknown
- 1976-06-24 CH CH809976A patent/CH623809A5/de not_active IP Right Cessation
- 1976-06-25 DK DK287476A patent/DK287476A/da unknown
- 1976-06-25 ZA ZA763802A patent/ZA763802B/xx unknown
- 1976-06-25 IL IL49916A patent/IL49916A0/xx unknown
- 1976-06-25 AT AT0467976A patent/AT365575B/de active
- 1976-06-25 GB GB26564/76A patent/GB1553595A/en not_active Expired
- 1976-06-26 JP JP51075954A patent/JPS525764A/ja active Pending
- 1976-06-28 BE BE168390A patent/BE843505A/fr not_active IP Right Cessation
- 1976-06-28 FR FR7619563A patent/FR2316943A1/fr active Granted
Non-Patent Citations (2)
Title |
---|
CHEMICAL ABSTRACTS, VOLUME 85 1976 123 751 H CITE JA - A - 76 01 461 TANABE SEIYAKU CO. ) * |
TETRAHEDRON LETTERS, NO. 51 1975 , PAGES 4599 - 4602 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2369260A1 (fr) * | 1976-08-06 | 1978-05-26 | Pfizer | 2-pyrrolidones 1,5-disubstituees et leurs procedes de preparation |
Also Published As
Publication number | Publication date |
---|---|
SE7607331L (sv) | 1976-12-28 |
ES449095A1 (es) | 1977-12-16 |
NL7606773A (nl) | 1976-12-29 |
JPS525764A (en) | 1977-01-17 |
FR2316943B1 (fr) | 1978-11-03 |
LU75235A1 (fr) | 1977-03-16 |
DK287476A (da) | 1976-12-28 |
ZA763802B (en) | 1977-05-25 |
IL49916A0 (en) | 1976-08-31 |
CH623809A5 (en) | 1981-06-30 |
AT365575B (de) | 1982-01-25 |
DE2528664A1 (de) | 1977-01-13 |
BE843505A (fr) | 1976-12-28 |
GB1553595A (en) | 1979-09-26 |
ATA467976A (de) | 1981-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE846335R (fr) | (polyalcoxy-phenyl)-4-pyrrolidinones-2 et medicaments qui en contiennent | |
BE860877A (fr) | Spirolactones steroidiques et medicaments qui en contiennent | |
FR2282892A1 (fr) | Derives de la purine et medicaments qui en contiennent | |
FR2295739A1 (fr) | Oxo-20 homopregnanes et medicaments qui en contiennent | |
BE861451A (fr) | Phenyl-5 oxazolidines et thiazolidines, et medicaments qui en contiennent | |
BE865870A (fr) | Derives du benzimidazole et medicaments qui en contiennent | |
FR2316943A1 (fr) | Pyrrolidones et medicaments qui en contiennent | |
FR2312240A1 (fr) | Derives du prostane et medicaments qui en contiennent | |
FR2326927A1 (fr) | Steroides insatures en 15 et medicaments qui en contiennent | |
FR2281123A1 (fr) | Oxo-20 pregnanes et medicaments qui en contiennent | |
BE849788A (fr) | Ethers d'imidazolyl-oximes et medicaments qui en contiennent | |
BE852089A (fr) | Androstenones et medicaments qui en contiennent | |
FR2287224A1 (fr) | Derives de la pyridine et medicaments qui en contiennent | |
DK194776A (da) | Antibakterielle midler og mellemprodukter dertil | |
FR2287908A1 (fr) | Hydroxy-7 oestradiols et medicaments qui en contiennent | |
BE849346R (fr) | Pyrrolidones et medicaments qui en contiennent | |
FR2316941A1 (fr) | Pyrrolidones et medicaments qui en contiennent | |
FR2342973A1 (fr) | Azapurines et medicaments contenant ces substances | |
FR2307526A1 (fr) | Oxo-11 prostaglandines et medicaments qui en contiennent | |
BE788322A (fr) | 3,4-dihydro-2h-isoquinoleine-1-ones et medicaments qui en contiennent | |
FR2347925A1 (fr) | Medicaments, cosmetiques et pesticides renfermant des fluoroacyl-resorcines | |
FR2343477A1 (fr) | Nouvelles phenylpyridylhydantoines substituees et medicament les contenant | |
BE843351A (fr) | Pyrrolidones et medicaments qui en contiennent | |
FR2283674A1 (fr) | Homo-steroides et medicaments qui en renferment | |
FR2313066A1 (fr) | Oxadiazines et medicaments qui en contiennent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |